More Life Sciences Articles

Life Sciences

Benchmark Metrics for Pharma Companies: Indexing allows cross-industry law department comparisons

This article covers two topics: benchmark metrics for pharmaceutical company law departments and indexing as a method to create comparability between benchmarks that have widely different scales. To address both topics, General Counsel Metrics, LLC, which conducts the world’s largest law...

Read More

Life Sciences

When the Stakes Are Highest: Hard work drives enviable track record in Hatch-Waxman litigation

MCC: Share a little bit with us about your practice at Fish & Richardson and how the firm works with life sciences companies. Singer: Fish has the premier patent litigation practice in the world, handling approximately twice as many patent cases as our nearest competitor. Our life...

Read More

Life Sciences

Biosimilars: Poised to Turn to Inter Partes Review to Resolve Patent Disputes

On March 6, 2015, the U.S. Food and Drug Administration (FDA) approved the first biosimilar drug in the U.S., Sandoz’s ZarxioTM, to treat cancer patients who are at increased risk for infection. A “biosimilar” is a biological product that is highly similar to an existing FDA‑...

Read More